vs
Side-by-side financial comparison of Lucid Diagnostics Inc. (LUCD) and OLB GROUP, INC. (OLB). Click either name above to swap in a different company.
OLB GROUP, INC. is the larger business by last-quarter revenue ($1.8M vs $1.2M, roughly 1.5× Lucid Diagnostics Inc.). OLB GROUP, INC. runs the higher net margin — -83.7% vs -858.5%, a 774.8% gap on every dollar of revenue. On growth, Lucid Diagnostics Inc. posted the faster year-over-year revenue change (3.3% vs -35.2%). Over the past eight quarters, Lucid Diagnostics Inc.'s revenue compounded faster (7.9% CAGR vs -28.7%).
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
OLB Group, Inc. is a global financial technology provider offering omnichannel payment processing solutions, e-commerce enablement tools, and digital banking services for small and medium-sized enterprises across North America, Europe, and key Asia-Pacific markets. Its core segments include merchant services, crypto payment integration, and cloud-based business management platforms.
LUCD vs OLB — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $1.8M |
| Net Profit | $-10.4M | $-1.5M |
| Gross Margin | — | — |
| Operating Margin | -971.0% | -83.7% |
| Net Margin | -858.5% | -83.7% |
| Revenue YoY | 3.3% | -35.2% |
| Net Profit YoY | 16.0% | 67.5% |
| EPS (diluted) | $-0.10 | $-0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.8M | ||
| Q3 25 | $1.2M | $2.3M | ||
| Q2 25 | $1.2M | $2.3M | ||
| Q1 25 | $828.0K | $2.3M | ||
| Q4 24 | $1.2M | $2.7M | ||
| Q3 24 | $1.2M | $3.1M | ||
| Q2 24 | $976.0K | $3.5M | ||
| Q1 24 | $1.0M | $3.5M |
| Q4 25 | — | $-1.5M | ||
| Q3 25 | $-10.4M | $-1.2M | ||
| Q2 25 | $-4.4M | $-2.1M | ||
| Q1 25 | $-26.9M | $-1.1M | ||
| Q4 24 | $-11.5M | $-4.6M | ||
| Q3 24 | $-12.4M | $-1.6M | ||
| Q2 24 | $-11.0M | $-2.6M | ||
| Q1 24 | $-10.6M | $-2.4M |
| Q4 25 | — | -83.7% | ||
| Q3 25 | -971.0% | -49.1% | ||
| Q2 25 | -978.8% | -74.8% | ||
| Q1 25 | -1508.1% | -36.6% | ||
| Q4 24 | -1033.8% | -166.0% | ||
| Q3 24 | -997.8% | -52.9% | ||
| Q2 24 | -1146.7% | -74.3% | ||
| Q1 24 | -1078.1% | -82.6% |
| Q4 25 | — | -83.7% | ||
| Q3 25 | -858.5% | -50.8% | ||
| Q2 25 | -381.7% | -93.7% | ||
| Q1 25 | -3249.8% | -46.9% | ||
| Q4 24 | -964.2% | -167.1% | ||
| Q3 24 | -1055.5% | -52.9% | ||
| Q2 24 | -1127.6% | -75.2% | ||
| Q1 24 | -1060.1% | -67.8% |
| Q4 25 | — | $-0.48 | ||
| Q3 25 | $-0.10 | $-0.13 | ||
| Q2 25 | $-0.08 | $-0.66 | ||
| Q1 25 | $-0.52 | $-0.47 | ||
| Q4 24 | $-0.17 | $-3.55 | ||
| Q3 24 | $-0.25 | $-0.92 | ||
| Q2 24 | $-0.23 | $-1.49 | ||
| Q1 24 | $-0.40 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.3M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $25.8M | $4.6M |
| Total Assets | $53.2M | $12.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $47.3M | — | ||
| Q2 25 | $31.1M | — | ||
| Q1 25 | $25.2M | $29.3K | ||
| Q4 24 | $22.4M | $27.4K | ||
| Q3 24 | $14.5M | $41.3K | ||
| Q2 24 | $24.9M | $53.3K | ||
| Q1 24 | $24.8M | $3.3K |
| Q4 25 | — | $4.6M | ||
| Q3 25 | $25.8M | $5.3M | ||
| Q2 25 | $7.9M | $6.4M | ||
| Q1 25 | $-5.4M | $2.3M | ||
| Q4 24 | $5.4M | $3.2M | ||
| Q3 24 | $6.3M | $6.7M | ||
| Q2 24 | $16.0M | $8.3M | ||
| Q1 24 | $11.9M | $11.0M |
| Q4 25 | — | $12.3M | ||
| Q3 25 | $53.2M | $12.2M | ||
| Q2 25 | $38.7M | $12.4M | ||
| Q1 25 | $32.8M | $12.5M | ||
| Q4 24 | $30.7M | $12.7M | ||
| Q3 24 | $22.6M | $15.9M | ||
| Q2 24 | $34.1M | $16.6M | ||
| Q1 24 | $32.0M | $18.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.9M | $-1.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $-10.9M | $-115.5K | ||
| Q2 25 | $-10.5M | $-1.0M | ||
| Q1 25 | $-12.5M | $-155.8K | ||
| Q4 24 | $-9.9M | $-2.6M | ||
| Q3 24 | $-10.2M | $-376.7K | ||
| Q2 24 | $-11.5M | $-785.5K | ||
| Q1 24 | $-12.6M | $-424.7K |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LUCD
Segment breakdown not available.
OLB
| Transaction And Processing Fees | $1.7M | 94% |
| Other | $99.2K | 6% |
